When stored in the freezer, our XC Gel packs have 10x more cooling power than standard gel packs
The exact ways in which BPC-157 influences tendon healing are currently being clarified
Best paired with: Elysium Light Bed, Ammortal Chamber, NanoVi, PEMF Immune Support Plays a key role in regluating the immune system, helps the body fight infections and decreases inflammation
Lead times range from 46 weeks depending on supplier and region
The available evidence consists primarily of animal studies and limited early-phase human trials, with no published phase III clinical trial data demonstrating efficacy in inflammatory bowel disease (IBD).[1][2] The literature describes BPC-157 as a stable gastric pentadecapeptide that was tested in phase II clinical trials for inflammatory bowel disease (referenced as PL 14736), with reports indicating it was "safe" and had "no side effects." However, a 2025 review emphasizes that BPC-157 "has not been approved for use in standard medicine by the FDA and other global regulatory authorities due to the absence of sufficient and comprehensive clinical studies confirming its health benefits in humans."[1][3][2] The preclinical evidence is extensive but limited to animal models
to loosen regulations on peptides, which are often pitched as a quick way to build muscle, heal injuries or appear younger
